Lee Ainslie Canopy Growth Corp Transaction History

Maverick Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.75 - $3.14 $215,589 - $386,829	123,194 Added 124.87%	221,848 $388,000
Q4 2022 Feb 14, 2023	BUY	$2.09 - $4.32 $126,261 - $260,979	60,412 Added 157.97%	98,654 $227,000
Q3 2022 Nov 14, 2022	BUY	$2.24 - $4.18 $85,662 - $159,851	38,242 New	38,242 $104,000
Q4 2021 Feb 14, 2022	SELL	$8.73 - $15.27 $369,191 - $645,768	-42,290 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.52 - $23.95 $558,119 - $988,679	41,281 Added 4091.28%	42,290 $586,000

Q2 2021 Aug 16, 2021	BUY	$22.12 - $32.06 $22,319 - $32,348	1,009 New	1,009 $24,000
Q1 2021 May 17, 2021	SELL	$26.12 - $52.17 $173,227 - $345,991	-6,632 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.05 - $29.0 $93,179 - $192,328	6,632 New	6,632 $163,000

8.33M

400

Ticker CGC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 480,284,000
Market Cap $3.12B
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.